Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
171 | 58457 | 38.3 | 73% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
43 | 2 | JOURNAL OF LIPID RESEARCH//HDL//LIPOPROTEINS | 30963 |
419 | 2 | STATINS//EZETIMIBE//SIMVASTATIN | 16502 |
1649 | 2 | LIPOPROTEINA//FAMILIAL HYPERCHOLESTEROLEMIA//APOLIPOPROTEINA | 6893 |
3293 | 2 | CHOLESTEROL//HYPOCHOLESTEROLEMIA//HLTH FAMILY STUDIES | 1869 |
3544 | 2 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 1358 |
3868 | 2 | POLICOSANOL//TRIACONTANOL//OCTACOSANOL | 872 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MONASCUS | authKW | 1502694 | 6% | 80% | 137 |
2 | CITRININ | authKW | 1159506 | 7% | 55% | 154 |
3 | MONASCUS PURPUREUS | authKW | 938232 | 4% | 78% | 88 |
4 | STATINS | authKW | 881674 | 6% | 47% | 3461 |
5 | JOURNAL OF LIPID RESEARCH | journal | 477479 | 5% | 32% | 2744 |
6 | LIPOPROTEINA | authKW | 467195 | 2% | 73% | 1178 |
7 | LIPOPROTEINS | authKW | 432445 | 4% | 34% | 2350 |
8 | TRIACONTANOL | authKW | 420706 | 2% | 70% | 44 |
9 | MONASCUS PIGMENTS | authKW | 378904 | 1% | 86% | 32 |
10 | ANKAFLAVIN | authKW | 355971 | 1% | 100% | 26 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 110766 | 14% | 3% | 7627 |
2 | Cardiac & Cardiovascular System | 98092 | 17% | 2% | 9735 |
3 | Biochemistry & Molecular Biology | 31478 | 23% | 1% | 12979 |
4 | Medical Laboratory Technology | 24638 | 4% | 3% | 2086 |
5 | Endocrinology & Metabolism | 18180 | 8% | 1% | 4549 |
6 | Medicine, General & Internal | 18080 | 10% | 1% | 5520 |
7 | Nutrition & Dietetics | 17858 | 5% | 1% | 2976 |
8 | Pharmacology & Pharmacy | 9869 | 10% | 1% | 5772 |
9 | Medicine, Research & Experimental | 9194 | 6% | 1% | 3330 |
10 | Hematology | 7328 | 4% | 1% | 2413 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOPROC ENGN SECT | 68456 | 0% | 100% | 5 |
2 | LIPID METAB | 59503 | 0% | 52% | 214 |
3 | LIPID CLIN | 49461 | 0% | 41% | 224 |
4 | BIOCHEM SCI TECHNOL | 46965 | 3% | 6% | 57 |
5 | CHESTNUT HILL HOSP | 43810 | 0% | 80% | 4 |
6 | SOFTWARE DATABASE GRP | 41074 | 0% | 100% | 3 |
7 | BCRC | 40261 | 1% | 18% | 16 |
8 | FOOD BIOMOL | 38543 | 1% | 22% | 13 |
9 | LIPOPROT ATHEROSCLEROSIS GRP | 35166 | 0% | 74% | 88 |
10 | DIPARTIMENTO BIOMORFOL | 34496 | 0% | 23% | 11 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF LIPID RESEARCH | 477479 | 5% | 32% | 2744 |
2 | ATHEROSCLEROSIS | 344332 | 5% | 25% | 2605 |
3 | JOURNAL OF CLINICAL LIPIDOLOGY | 135562 | 1% | 62% | 404 |
4 | CURRENT OPINION IN LIPIDOLOGY | 102366 | 1% | 38% | 502 |
5 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 91753 | 2% | 15% | 1134 |
6 | ARTERIOSCLEROSIS AND THROMBOSIS | 51767 | 1% | 34% | 284 |
7 | ATHEROSCLEROSIS SUPPLEMENTS | 48628 | 0% | 57% | 158 |
8 | ARTERIOSCLEROSIS | 44241 | 0% | 34% | 243 |
9 | METABOLISM-CLINICAL AND EXPERIMENTAL | 31631 | 1% | 8% | 732 |
10 | LIPIDS IN HEALTH AND DISEASE | 28685 | 1% | 19% | 285 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MONASCUS | 1502694 | 6% | 80% | 137 | Search MONASCUS | Search MONASCUS |
2 | CITRININ | 1159506 | 7% | 55% | 154 | Search CITRININ | Search CITRININ |
3 | MONASCUS PURPUREUS | 938232 | 4% | 78% | 88 | Search MONASCUS+PURPUREUS | Search MONASCUS+PURPUREUS |
4 | STATINS | 881674 | 6% | 47% | 3461 | Search STATINS | Search STATINS |
5 | LIPOPROTEINA | 467195 | 2% | 73% | 1178 | Search LIPOPROTEINA | Search LIPOPROTEINA |
6 | LIPOPROTEINS | 432445 | 4% | 34% | 2350 | Search LIPOPROTEINS | Search LIPOPROTEINS |
7 | TRIACONTANOL | 420706 | 2% | 70% | 44 | Search TRIACONTANOL | Search TRIACONTANOL |
8 | MONASCUS PIGMENTS | 378904 | 1% | 86% | 32 | Search MONASCUS+PIGMENTS | Search MONASCUS+PIGMENTS |
9 | ANKAFLAVIN | 355971 | 1% | 100% | 26 | Search ANKAFLAVIN | Search ANKAFLAVIN |
10 | MONASCUS PILOSUS | 354979 | 1% | 79% | 33 | Search MONASCUS+PILOSUS | Search MONASCUS+PILOSUS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RAMASAMY, I , (2016) UPDATE ON THE MOLECULAR BIOLOGY OF DYSLIPIDEMIAS.CLINICA CHIMICA ACTA. VOL. 454. ISSUE . P. 143 -185 | 422 | 75% | 4 |
2 | ADAMS, SP , TSANG, M , WRIGHT, JM , (2012) LIPID LOWERING EFFICACY OF ATORVASTATIN.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - | 577 | 67% | 1 |
3 | ZANNIS, VI , KARDASSIS, D , ZANNI, EE , (1993) GENETIC MUTATIONS AFFECTING HUMAN LIPOPROTEINS, THEIR RECEPTORS, AND THEIR ENZYMES.ADVANCES IN HUMAN GENETICS. VOL. 21. ISSUE . P. 145-379 | 646 | 86% | 54 |
4 | RAMASAMY, I , (2014) RECENT ADVANCES IN PHYSIOLOGICAL LIPOPROTEIN METABOLISM.CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL. 52. ISSUE 12. P. 1695 -1727 | 271 | 87% | 20 |
5 | LEMAN, LJ , MARYANOFF, BE , GHADIRI, MR , (2014) MOLECULES THAT MIMIC APOLIPOPROTEIN A-I: POTENTIAL AGENTS FOR TREATING ATHEROSCLEROSIS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 57. ISSUE 6. P. 2169 -2196 | 237 | 92% | 18 |
6 | MIKHAILIDIS, DP , ELISAF, M , RIZZO, M , BERNEIS, K , GRIFFIN, B , ZAMBON, A , ATHYROS, V , DE GRAAF, J , MARZ, W , PARHOFER, KG , ET AL (2011) "EUROPEAN PANEL ON LOW DENSITY LIPOPROTEIN (LDL) SUBCLASSES": A STATEMENT ON THE PATHOPHYSIOLOGY, ATHEROGENICITY AND CLINICAL SIGNIFICANCE OF LDL SUBCLASSES.CURRENT VASCULAR PHARMACOLOGY. VOL. 9. ISSUE 5. P. 533 -571 | 298 | 76% | 55 |
7 | RADER, DJ , TOTH, PP , BARTER, PJ , ROSENSON, RS , BODEN, WE , CHAPMAN, MJ , CUCHEL, M , D'AGOSTINO, RB , DAVIDSON, MH , DAVIDSON, WS , ET AL (2013) HIGH-DENSITY LIPOPROTEINS: A CONSENSUS STATEMENT FROM THE NATIONAL LIPID ASSOCIATION.JOURNAL OF CLINICAL LIPIDOLOGY. VOL. 7. ISSUE 5. P. 484 -525 | 197 | 87% | 73 |
8 | SCHMIDT, K , NOUREEN, A , KRONENBERG, F , UTERMANN, G , (2016) THEMATIC REVIEW SERIES: LIPOPROTEIN (A): COMING OF AGE AT LAST STRUCTURE, FUNCTION, AND GENETICS OF LIPOPROTEIN (A).JOURNAL OF LIPID RESEARCH. VOL. 57. ISSUE 8. P. 1339 -1359 | 177 | 83% | 7 |
9 | KINGWELL, BA , CHAPMAN, MJ , KONTUSH, A , MILLER, NE , (2014) HDL-TARGETED THERAPIES: PROGRESS, FAILURES AND FUTURE.NATURE REVIEWS DRUG DISCOVERY. VOL. 13. ISSUE 6. P. 445 -464 | 166 | 85% | 77 |
10 | KONTUSH, A , CHAPMAN, MJ , (2006) FUNCTIONALLY DEFECTIVE HIGH-DENSITY LIPOPROTEIN: A NEW THERAPEUTIC TARGET AT THE CROSSROADS OF DYSLIPIDEMIA, INFLAMMATION, AND ATHEROSCLEROSIS.PHARMACOLOGICAL REVIEWS. VOL. 58. ISSUE 3. P. 342 -374 | 275 | 64% | 338 |
Classes with closest relation at Level 3 |